Controlled-release and antibacterial studies of doxycycline-loaded poly(ε-caprolactone) microspheres

Journal of Saudi Chemical Society

Volumn 18, Issue 5, 2014, Pages 566-573

  Raval, Jignesh P ^a   Naik, Deep R ^a   Amin, Keyur A ^a   Patel, Pradip S ^a  

^a Ashok & Rita Patel Institute of Integrated Study and Research in Biotechnology and Allied Sciences   (India)

Author keywords

Antibacterial studies; Controlled release; Doxycycline; Poly( caprolactone); Solvent evaporation technique

Indexed keywords

EID: 84908620922     PISSN: 13196103     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jscs.2011.11.004     Document Type: Article

References (26)

1. Ali J., Khar R., Ahuja A., Kalra R. Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation. Int. J. Pharm. 2002, 238:93-103.
2. Dongming P., Kelong H., Yanfei L., Suqin L., Hong W., Han X. Preparation of carbon dioxide/propylene oxide/ε-caprolactone copolymers and their drug release behaviors. Polym. Bull. 2007, 59:117-125.
3. Giovagnoli S., Blasi P., Ricci M., Schoubben A., Perioli L., Rossi C. Physicochemical characterization and release mechanism of a novel prednisone biodegradable microspheres formulation. J. Pharm. Sci. 2008, 97:303-317.
4. Govender S., Pillay V., Chetty D.J., Essack S.Y., Dangor C.M., Govender T. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. Int. J. Pharm. 2005, 306:24-40.
5. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52:1145-1149.
6. Joseph N.J., Lakshmi S., Jayakrishnan A. A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. J. Control Release 2002, 79:1-79.
7. Kim B., Hwang S., Park J., Park H. Characteristics of felodipine loaded poly (ε-caprolactone) microspheres. J. Microencapsul. 2003, 22:193-203.
8. Korsmeyer R.W., Gurny R., Doelker E.M., Buri P., Peppas N.A. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15:25-35.
9. Krajewski, A., Kirsch, M., Ravaglioli, A., Mazzocchi, M., 2000. A survey on the drug delivery systems. In: Ravaglioli, A., Krajewski, A. (Eds.), Drug Delivery Systems. Proceedings of the Sixth International Meeting and Seminar on Ceramics, Cells and Tissues. CNR, Faenza, pp. 3-13.
10. Kumar A., Sharma P., Banik A. Microencapsulation as a novel drug delivery system. Int. Pharm. Sci. 2011, 1:1-7.
11. Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol. Immunol. 2002, 17:267-271.
12. Lionzo M., Re M., Guterres S., Pholmann A. Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly (ε-caprolactone) blends to control the release of drug mode. J. Microencapsul. 2007, 4:175-186.
13. Mombelli, A., Winkelhoff, A., 1997. In: Lang, N., Karring, T., Lindhe, J. (Eds.), Proceedings of the 2nd European Workshop on Periodontology. Quintessence, London, p. 38.
14. Mundargi R., Srirangarajan S., Agnihotri S., Patil S., Ravindra S., Setty S., Aminabhavi T. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly (ε-caprolactone) for controlled delivery of doxycycline. J. Control Release 2007, 119:59-68.
15. Patel P., Mundargi R., Babu V., Jain D., Rangaswamy V., Aminabhavi T. Microencapsulation of doxycycline into poly(lactide-coglycolide) by spray drying technique: effect of polymer molecular weight on process parameters. J. Appl. Polym. Sci. 2008, 108:4038-4046.
16. Paul W., Sharma C. Ceramic drug delivery: perspective. J. Biomater. Appl. 2003, 17:253-264.
17. Perez M., Zinnuti C., Lamprecht A., Ubrich N., Astier A., Hoffman M., Bodmeier R., Maincent P. The preparation and the evaluation of poly (ε-caprolactone) microparticles containing both a lipophilic and hydrophilic drug. J. Control Release 2000, 65:429-438.
18. Pitcher G., Newman H., Strahan J. Access to subgingival plaque by disclosing agents using mouthrinsing and direct irrigation. J. Clin. Periodontol. 1980, 7:300-308.
19. Quderaa F.V. Anti-plaque agents: rationale and prospects of prevention of gingivitis and periodontal disease. J. Clin. Periodontol. 1991, 18:447-454.
20. Schwendeman, S., Cui, C., 2001. Biocompatible polymeric delivery systems having functional groups attached to the surface [6326,021]. US Patent.
21. Sehra S., Dhake A.S. Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate. J. Microencapsul. 2005, 22:521-528.
22. Seymour R., Heasman P. Tetracyclines in the management of periodontal diseases. J. Clin. Periodontol. 1995, 22:22-35.
23. Silvio L., Bonfield W. Biodegradable drug delivery system for the treatment of bone infection and repair. J. Mater. Sci. Mater. Med. 1999, 10:653-658.
24. Sinha V., Bansal K., Kaushik R., Kumria R., Trehan A. Poly (ε-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 2004, 278:11-23.
25. Stratton, C., Lorian, V., 1996. Mechanisms of action for antimicrobial agents: general principals and mechanisms for selected classes of antibiotics. Antibiotics in Laboratory Medicine, fourth ed. Springer, Berlin.
26. Vanderkerchove B., Quirynen M., Steenberghe D. The use of tetracycline-containing controlled-release fibers in the treatment of refractory periodontitis. J. Clin. Periodontol. 1997, 68:353-361.